Vincent O'Neill, Chief Medical Officer at BioXcel Therapeutics, Inc. (BTAI), sold 29,713 shares at $30.00 ($891K) on 2023-01-20, disclosed to the SEC on 2023-01-24.
Open-market sale of $891k BTAI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BTAI | SELL | 2024-09-17 | $95 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $200 | — | Filing → |
| BTAI | SELL | 2024-04-08 | $432 | — | Filing → |